Background: Nonalcoholic fatty liver disease (NAFLD) is emerging as a public health issue
worldwide and is highly prevalent in patients with type 2 diabetes mellitus (T2DM). However …

Context Nonalcoholic fatty liver disease (NAFLD) prevalence is high, especially in patients
with obesity and type 2 diabetes, and is expected to rise steeply in the coming decades …

Introduction Non-alcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver
disease, with type 2 diabetes mellitus (T2DM) as a major predictor. Insulin resistance and …

BACKGROUND & AIMS: To estimate the prevalence of non-alcoholic fatty liver disease
(NAFLD) in type 1 diabetic individuals, and to evaluate whether NAFLD is associated with …

Objective. We studied the prevalence of nonalcoholic fatty liver disease (NAFLD) and its
clinical correlates in a population of patients with type 2 diabetes mellitus (T2DM). Methods …

The global prevalence of non‐alcoholic fatty liver disease (NAFLD) is rising, along with the
epidemic of diabesity. NAFLD is present in> 70% of individuals with type 2 diabetes …

Non-Alcoholic Fatty Liver Disease (NAFLD) is the most common cause of hepatic
dysfunction encountered in general practice. A large proportion of individuals with type 2 …

Background & Aims Although non-alcoholic fatty liver disease (NAFLD), non-alcoholic
steatohepatitis (NASH) and NASH with advanced fibrosis are closely associated with type 2 …

OBJECTIVE—To determine the prevalence of nonalcoholic fatty liver disease (NAFLD) in
type 2 diabetic population and to compare the prevalence of cardiovascular disease (CVD) …

Context: Nonalcoholic fatty liver disease (NAFLD) is increasingly diagnosed worldwide and
is the most common chronic liver disease in Western countries. In this review, we discuss the …